Gene Therapy for X-Linked Retinitis Pigmentosa: Implications for Clinical Practice Right Now

AMA PRA Category 1 Credit(s)^TM, COPE CE Credit(s)

1.00 CME COPE: XLRP: Diagnosis, genetic testing, clinical trials, and support. Exp 6/30/23

Multiple Sclerosis Management: Shedding Light on the Patient Perspective

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s)

1.00 CME/CE: Extensive patient data provide scientific discussion on under-recognized considerations in the long-term management of MS. Exp 12/16/22

Cockayne Syndrome: Following the Patient Journey to Diagnosis, Treatment, and Management

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s)

An expert panel will provide pediatricians and specialists with the tools needed to recognize signs and symptoms, make appropriate referrals to specialists, and coordinate care.

New Directions in Cervical Cancer: Employing a Multidisciplinary Approach to Optimal Patient Care – A 3-Part Podcast Series

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists, ANCC Contact Hour(s)

1.50 CME CE: New therapies, new sequencing and management strategies, and a critical need for expert guidance are shifting CC treatment. Exp 4/23/23

Corneal Toxicity in Patients Receiving Antibody–Drug Conjugates for the Treatment of Cancer

AMA PRA Category 1 Credit(s)^TM

1.25 CME: Expert faculty provides guidelines on monitoring and managing corneal toxicities due to antibody-drug conjugates. Exp 1/4/23

Current and Emerging Strategies for Severe Vernal Keratoconjunctivitis

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s)

1.00 CME CE: Podcast discusses properly diagnosing and treating VKC according to disease severity, and differentiating it from other ocular allergies. Exp 11/8/22

Evolving Treatment Approaches for Generalized Myasthenia Gravis to Reduce Disease Burden and Improve Daily Living

AMA PRA Category 1 Credit(s)^TM

1.00 CME: Specific subtypes of gMG and the clinical characteristics, biomarkers, and patient factors essential to optimal treatment decisions. Exp 11/30/22